Antisense oligonucleotides (ASOs) are 15–25 nt oligonucleotides designed to tie complementary RNA targets for the degradation. They are synthesized so that they can be used to block disease processes by altering the synthesis of a specific protein. ASOs offers promising treatment options for a range of medical disorders. They facilitate the development of therapeutics affecting protein targets which cannot be treated with protein therapeutics. They can target a particular malfunctioning gene ... Read more

Antisense oligonucleotides (ASOs) are 15–25 nt oligonucleotides designed to tie complementary RNA targets for the degradation. They are synthesized so that they can be used to block disease processes by altering the synthesis of a specific protein. ASOs offers promising treatment options for a range of medical disorders. They facilitate the development of therapeutics affecting protein targets which ... Read more

Market Overview:
Antisense oligonucleotides are short segments of synthetic nucleic acid sequences that are used to target messenger RNA (mRNA) in the human body. They help in down-regulating gene expression by binding to complementary mRNA sequences through Watson-Crick base pairing, thereby preventing translation into targeted proteins. Antisense oligonucleotides find applications in the treatment of various genetic disorders including Duchenne muscular dystrophy (DMD) and spinal ... Read more